Home > Press Releases > Patient Engagement Solutions Market

Patient Engagement Solutions Market Likely to Surpass ~USD 64 billion by 2035

Report Code: HC-25864  |  Published in: Apr 2026, By MarketGenics  |  Number of pages: 302
Get PDF
Buy

Global Patient Engagement Solutions Market Forecast 2035:

According to the report, the global patient engagement solutions market is likely to grow from USD 25.6 Billion in 2025 to USD 64.4 Billion in 2035 at a highest CAGR of 9.7% during the time period. The global patient engagement solutions market continues to grow at a fast pace, likewise is the uptake of digital health technologies, the move toward value-based care, and the growing need for enhancement of the patient experience. Several healthcare organizations have implemented patient engagement platforms so they can simplify communication between healthcare providers and patients; better manage chronic diseases; and increase patient compliance to treatment.

In doing this, many healthcare providers are improving their operational efficiency and clinical outcomes. The adoption of these platforms and solutions is further being driven by governmental policies aimed at promoting telehealth, interoperability, and patient access to their electronic health records throughout the U.S. and Canada, as well as Europe.

Additionally, by providing access to real-time patient interactions through artificial intelligence-enabled platforms; mobile health applications; and remote monitoring applications, healthcare providers are able to utilize predictive analytics and provide evidence-based data to better predict, prevent and treat patients' needs; reduce hospital readmissions; and manage the health of populations.

Key Driver, Restraint, and Growth Opportunity Shaping the Global Patient Engagement Solutions Market

The global patient engagement solutions market expanded because healthcare providers increasingly use digital platforms to enhance their patient communication and care coordination operations. The engagement solutions have gained usage because patients now use smartphones and wearables, which enable the system to send appointment reminders and deliver personalized health content while enabling remote monitoring that improves adherence and operational efficiency.

The United States health systems that implemented integrated mobile engagement applications in 2025 experienced higher patient satisfaction scores as their primary outcome.

However, the key obstacle which needs to be addressed involves maintaining consistent patient engagement throughout different demographic groups, especially older adults and people who struggle with digital skills. Providers frequently direct extra money for training purposes and user assistance and for developing easy-to-use systems which create product design obstacles that limit their ability to expand their reach while providing affordable access to their engagement solutions.

The engagement solutions face particular challenges in rural and underserved areas because digital access to these regions remains limited.

Furthermore, patient engagement tools which exists today are able to undergo better development through its integration into chronic disease management programs, which treat diabetes and heart failure and COPD patients. Engagement platforms which include educational content and real-time monitoring and two-way communication features enable patients to control their own health while achieving better health results.

The Canadian and Australian pilot programs which used integrated engagement systems demonstrated their ability to enhance clinical outcomes while decreasing hospital readmission rates for chronic care patients.

Expansion of Global Patient Engagement Solutions Market

Digital Health Adoption, Value-Based Care, and AI-Driven Patient Engagement Driving the Global Patient Engagement Solutions Market Expansion

  • The patient engagement solutions market is experiencing strong growth globally owing to a faster-than-average rate of implementation of digital transformation across health care providers and systems, which is improving the delivery of care; satisfying the mandates of value-based care; and accommodating rising patient expectations. Increased usage of electronic health records (EHRs), mobile health platforms, and telehealth is allowing patients to engage in real-time with their providers during all aspects of the care continuum (appointments, follow-up visits via technology, and management of chronic conditions).
  • The movement toward value-based care models is requiring both providers and payers to invest in engagement platforms that promote adherence, reduce hospital readmission rates, and provide quality metrics. Advanced Artificial Intelligence (AI)-driven personalization and predictive analytics are enabling tailored communication, risk stratification, and targeted outreach to patients, thereby greatly enhancing patient experience and patient outcomes.
  • For example, AI chatbots and virtual assistants are increasingly found within patient portals to provide real-time responses and personal assistance. Furthermore, the use of AI-driven engagement technologies within the health care ecosystem is predicted to quickly accelerate in the coming years (in response to growing demand for intelligent solutions).
  • Collectively, the following three components create a strong momentum for continued growth across the patient engagement solutions market: 1) digital transformation; 2) regulatory push for patient access to information and data sharing; and 3) availability of AI-driven engagement platforms.

Regional Analysis of Global Patient Engagement Solutions Market

  • North America leads in patient engagement solutions market because its digital health system delivers advanced healthcare services while its citizens face multiple chronic conditions and its existing reimbursement system provides financial support for medical services. The CDC reports that a major portion of U.S. adults experience chronic illnesses which demand ongoing treatment and monitoring, thereby increasing the necessity for remote patient engagement solutions and telehealth services.
  • The implementation of digital engagement platforms receives support from Medicare and private insurance coverage which drives their widespread use. Moreover, North America maintains its market leadership because healthcare providers make substantial investments in AI-based patient portals and mobile health applications and combined electronic health record systems.
  • The Asia Pacific region will experience its most significant expansion because healthcare facilities increasingly adopt digital practices, people become more informed about telehealth services, and healthcare providers work to develop better medical access for remote patients. India and China are developing economical digital health solutions to create mobile health applications which will enable them to connect with large populations.
  • The Ayushman Bharat Digital Mission in India has created opportunities for millions of patients to obtain digital health services and remote medical treatment. The combination of domestic startup investments and partnerships with international healthcare technology companies has resulted in double-digit expansion for the Asia Pacific market, making it the fastest-growing region in worldwide patient engagement solutions.

Prominent players operating in global patient engagement solutions market include prominent companies such as AdvancedMD, Inc., athenahealth, Inc., CareCloud, Inc., Cerner Corporation, Cognizant Technology Solutions Corporation, eClinicalWorks LLC, Epic Systems Corporation, Get Real Health, GetWellNetwork, Inc., IBM Corporation, IQVIA Inc., McKesson Corporation, MEDITECH, Oneview Healthcare PLC, Oracle Corporation, Orion Health Group Limited, Phreesia, Inc., Tebra Technologies, Inc., Veradigm Inc., Wolters Kluwer N.V., along with several other key players.

The global patient engagement solutions market has been segmented as follows:

Global Patient Engagement Solutions Market Analysis, by Component

  • Software
  • Services
    • Consulting Services
    • Implementation & Integration Services
    • Training & Education
    • Support & Maintenance Services

Global Patient Engagement Solutions Market Analysis, by Deployment Mode

  • On-Premises
  • Cloud
  • Hybrid

Global Patient Engagement Solutions Market Analysis, by Therapeutic Area

  • Chronic Diseases
    • Diabetes
    • Cardiovascular Diseases
    • Respiratory Diseases
    • Oncology
    • Others
  • Women’s Health
  • Mental Health
  • Fitness & Wellness
  • Others

Global Patient Engagement Solutions Market Analysis, by Functionality

  • Patient Communication
  • Patient Education
  • Appointment Scheduling & Reminders
  • Billing & Payments
  • Patient Feedback & Surveys
  • Care Plan Management
  • Others

Global Patient Engagement Solutions Market Analysis, by Integration Type

  • Integrated Solutions
  • Standalone Solutions

Global Patient Engagement Solutions Market Analysis, by User Type

  • Inpatient Engagement
  • Outpatient Engagement

Global Patient Engagement Solutions Market Analysis, by Technology

  • Mobile Health (mHealth) Solutions
  • Telehealth & Telemedicine
  • Artificial Intelligence & Analytics
  • Wearables & Remote Monitoring Devices
  • Others

Global Patient Engagement Solutions Market Analysis, by Application

  • Health Management
  • Social & Behavioral Management
  • Financial Health Management
  • Home Health Management
  • Others

Global Patient Engagement Solutions Market Analysis, by End User

  • Healthcare Providers
    • Hospitals
    • Clinics
    • Ambulatory Care Centers
  • Payers
    • Private Insurance Companies
    • Government Payers
  • Patients/Individuals
  • Others

Global Patient Engagement Solutions Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Natures
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Natures
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Patient Engagement Solutions Market Outlook
      • 2.1.1. Patient Engagement Solutions Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Increasing adoption of digital health tools and telehealth platforms by healthcare providers.
        • 4.1.1.2. Rising focus on value-based care and improving patient experience and treatment adherence.
        • 4.1.1.3. Integration of AI and analytics for personalized patient engagement and predictive care management.
      • 4.1.2. Restraints
        • 4.1.2.1. High implementation complexity and challenges integrating with legacy EHR systems.
        • 4.1.2.2. Data privacy and regulatory compliance concerns limiting deployment.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Patient Engagement Solutions Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Patient Engagement Solutions Market Analysis, by Component
    • 6.1. Key Segment Analysis
    • 6.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
      • 6.2.1. Software
      • 6.2.2. Services
        • 6.2.2.1. Consulting Services
        • 6.2.2.2. Implementation & Integration Services
        • 6.2.2.3. Training & Education
        • 6.2.2.4. Support & Maintenance Services
  • 7. Global Patient Engagement Solutions Market Analysis, by Deployment Mode
    • 7.1. Key Segment Analysis
    • 7.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
      • 7.2.1. On-Premises
      • 7.2.2. Cloud
      • 7.2.3. Hybrid
  • 8. Global Patient Engagement Solutions Market Analysis, by Therapeutic Area
    • 8.1. Key Segment Analysis
    • 8.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Therapeutic Area, 2021-2035
      • 8.2.1. Chronic Diseases
        • 8.2.1.1. Diabetes
        • 8.2.1.2. Cardiovascular Diseases
        • 8.2.1.3. Respiratory Diseases
        • 8.2.1.4. Oncology
        • 8.2.1.5. Others
      • 8.2.2. Women’s Health
      • 8.2.3. Mental Health
      • 8.2.4. Fitness & Wellness
      • 8.2.5. Others
  • 9. Global Patient Engagement Solutions Market Analysis, by Functionality
    • 9.1. Key Segment Analysis
    • 9.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Functionality, 2021-2035
      • 9.2.1. Patient Communication
      • 9.2.2. Patient Education
      • 9.2.3. Appointment Scheduling & Reminders
      • 9.2.4. Billing & Payments
      • 9.2.5. Patient Feedback & Surveys
      • 9.2.6. Care Plan Management
      • 9.2.7. Others
  • 10. Global Patient Engagement Solutions Market Analysis, by Integration Type
    • 10.1. Key Segment Analysis
    • 10.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Integration Type, 2021-2035
      • 10.2.1. Integrated Solutions
      • 10.2.2. Standalone Solutions
  • 11. Global Patient Engagement Solutions Market Analysis, by User Type
    • 11.1. Key Segment Analysis
    • 11.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by User Type, 2021-2035
      • 11.2.1. Inpatient Engagement
      • 11.2.2. Outpatient Engagement
  • 12. Global Patient Engagement Solutions Market Analysis, by Technology
    • 12.1. Key Segment Analysis
    • 12.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 12.2.1. Mobile Health (mHealth) Solutions
      • 12.2.2. Telehealth & Telemedicine
      • 12.2.3. Artificial Intelligence & Analytics
      • 12.2.4. Wearables & Remote Monitoring Devices
      • 12.2.5. Others
  • 13. Global Patient Engagement Solutions Market Analysis, by Application
    • 13.1. Key Segment Analysis
    • 13.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 13.2.1. Health Management
      • 13.2.2. Social & Behavioral Management
      • 13.2.3. Financial Health Management
      • 13.2.4. Home Health Management
      • 13.2.5. Others
  • 14. Global Patient Engagement Solutions Market Analysis, by End User
    • 14.1. Key Segment Analysis
    • 14.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
      • 14.2.1. Healthcare Providers
        • 14.2.1.1. Hospitals
        • 14.2.1.2. Clinics
        • 14.2.1.3. Ambulatory Care Centers
      • 14.2.2. Payers
        • 14.2.2.1. Private Insurance Companies
        • 14.2.2.2. Government Payers
      • 14.2.3. Patients/Individuals
      • 14.2.4. Others
  • 15. Global Patient Engagement Solutions Market Analysis and Forecasts, by Region
    • 15.1. Key Findings
    • 15.2. Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 15.2.1. North America
      • 15.2.2. Europe
      • 15.2.3. Asia Pacific
      • 15.2.4. Middle East
      • 15.2.5. Africa
      • 15.2.6. South America
  • 16. North America Patient Engagement Solutions Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. North America Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Component
      • 16.3.2. Deployment Mode
      • 16.3.3. Therapeutic Area
      • 16.3.4. Functionality
      • 16.3.5. Integration Type
      • 16.3.6. User Type
      • 16.3.7. Technology
      • 16.3.8. Application
      • 16.3.9. End User
      • 16.3.10. Country
        • 16.3.10.1. USA
        • 16.3.10.2. Canada
        • 16.3.10.3. Mexico
    • 16.4. USA Patient Engagement Solutions Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Component
      • 16.4.3. Deployment Mode
      • 16.4.4. Therapeutic Area
      • 16.4.5. Functionality
      • 16.4.6. Integration Type
      • 16.4.7. User Type
      • 16.4.8. Technology
      • 16.4.9. Application
      • 16.4.10. End User
    • 16.5. Canada Patient Engagement Solutions Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Component
      • 16.5.3. Deployment Mode
      • 16.5.4. Therapeutic Area
      • 16.5.5. Functionality
      • 16.5.6. Integration Type
      • 16.5.7. User Type
      • 16.5.8. Technology
      • 16.5.9. Application
      • 16.5.10. End User
    • 16.6. Mexico Patient Engagement Solutions Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Component
      • 16.6.3. Deployment Mode
      • 16.6.4. Therapeutic Area
      • 16.6.5. Functionality
      • 16.6.6. Integration Type
      • 16.6.7. User Type
      • 16.6.8. Technology
      • 16.6.9. Application
      • 16.6.10. End User
  • 17. Europe Patient Engagement Solutions Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Europe Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Component
      • 17.3.2. Deployment Mode
      • 17.3.3. Therapeutic Area
      • 17.3.4. Functionality
      • 17.3.5. Integration Type
      • 17.3.6. User Type
      • 17.3.7. Technology
      • 17.3.8. Application
      • 17.3.9. End User
      • 17.3.10. Country
        • 17.3.10.1. Germany
        • 17.3.10.2. United Kingdom
        • 17.3.10.3. France
        • 17.3.10.4. Italy
        • 17.3.10.5. Spain
        • 17.3.10.6. Netherlands
        • 17.3.10.7. Nordic Countries
        • 17.3.10.8. Poland
        • 17.3.10.9. Russia & CIS
        • 17.3.10.10. Rest of Europe
    • 17.4. Germany Patient Engagement Solutions Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Component
      • 17.4.3. Deployment Mode
      • 17.4.4. Therapeutic Area
      • 17.4.5. Functionality
      • 17.4.6. Integration Type
      • 17.4.7. User Type
      • 17.4.8. Technology
      • 17.4.9. Application
      • 17.4.10. End User
    • 17.5. United Kingdom Patient Engagement Solutions Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Component
      • 17.5.3. Deployment Mode
      • 17.5.4. Therapeutic Area
      • 17.5.5. Functionality
      • 17.5.6. Integration Type
      • 17.5.7. User Type
      • 17.5.8. Technology
      • 17.5.9. Application
      • 17.5.10. End User
    • 17.6. France Patient Engagement Solutions Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Component
      • 17.6.3. Deployment Mode
      • 17.6.4. Therapeutic Area
      • 17.6.5. Functionality
      • 17.6.6. Integration Type
      • 17.6.7. User Type
      • 17.6.8. Technology
      • 17.6.9. Application
      • 17.6.10. End User
    • 17.7. Italy Patient Engagement Solutions Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Component
      • 17.7.3. Deployment Mode
      • 17.7.4. Therapeutic Area
      • 17.7.5. Functionality
      • 17.7.6. Integration Type
      • 17.7.7. User Type
      • 17.7.8. Technology
      • 17.7.9. Application
      • 17.7.10. End User
    • 17.8. Spain Patient Engagement Solutions Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Component
      • 17.8.3. Deployment Mode
      • 17.8.4. Therapeutic Area
      • 17.8.5. Functionality
      • 17.8.6. Integration Type
      • 17.8.7. User Type
      • 17.8.8. Technology
      • 17.8.9. Application
      • 17.8.10. End User
    • 17.9. Netherlands Patient Engagement Solutions Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Component
      • 17.9.3. Deployment Mode
      • 17.9.4. Therapeutic Area
      • 17.9.5. Functionality
      • 17.9.6. Integration Type
      • 17.9.7. User Type
      • 17.9.8. Technology
      • 17.9.9. Application
      • 17.9.10. End User
    • 17.10. Nordic Countries Patient Engagement Solutions Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Component
      • 17.10.3. Deployment Mode
      • 17.10.4. Therapeutic Area
      • 17.10.5. Functionality
      • 17.10.6. Integration Type
      • 17.10.7. User Type
      • 17.10.8. Technology
      • 17.10.9. Application
      • 17.10.10. End User
    • 17.11. Poland Patient Engagement Solutions Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Component
      • 17.11.3. Deployment Mode
      • 17.11.4. Therapeutic Area
      • 17.11.5. Functionality
      • 17.11.6. Integration Type
      • 17.11.7. User Type
      • 17.11.8. Technology
      • 17.11.9. Application
      • 17.11.10. End User
    • 17.12. Russia & CIS Patient Engagement Solutions Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Component
      • 17.12.3. Deployment Mode
      • 17.12.4. Therapeutic Area
      • 17.12.5. Functionality
      • 17.12.6. Integration Type
      • 17.12.7. User Type
      • 17.12.8. Technology
      • 17.12.9. Application
      • 17.12.10. End User
    • 17.13. Rest of Europe Patient Engagement Solutions Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Component
      • 17.13.3. Deployment Mode
      • 17.13.4. Therapeutic Area
      • 17.13.5. Functionality
      • 17.13.6. Integration Type
      • 17.13.7. User Type
      • 17.13.8. Technology
      • 17.13.9. Application
      • 17.13.10. End User
  • 18. Asia Pacific Patient Engagement Solutions Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Asia Pacific Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Component
      • 18.3.2. Deployment Mode
      • 18.3.3. Therapeutic Area
      • 18.3.4. Functionality
      • 18.3.5. Integration Type
      • 18.3.6. User Type
      • 18.3.7. Technology
      • 18.3.8. Application
      • 18.3.9. End User
      • 18.3.10. Country
        • 18.3.10.1. China
        • 18.3.10.2. India
        • 18.3.10.3. Japan
        • 18.3.10.4. South Korea
        • 18.3.10.5. Australia and New Zealand
        • 18.3.10.6. Indonesia
        • 18.3.10.7. Malaysia
        • 18.3.10.8. Thailand
        • 18.3.10.9. Vietnam
        • 18.3.10.10. Rest of Asia Pacific
    • 18.4. China Patient Engagement Solutions Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Component
      • 18.4.3. Deployment Mode
      • 18.4.4. Therapeutic Area
      • 18.4.5. Functionality
      • 18.4.6. Integration Type
      • 18.4.7. User Type
      • 18.4.8. Technology
      • 18.4.9. Application
      • 18.4.10. End User
    • 18.5. India Patient Engagement Solutions Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Component
      • 18.5.3. Deployment Mode
      • 18.5.4. Therapeutic Area
      • 18.5.5. Functionality
      • 18.5.6. Integration Type
      • 18.5.7. User Type
      • 18.5.8. Technology
      • 18.5.9. Application
      • 18.5.10. End User
    • 18.6. Japan Patient Engagement Solutions Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Component
      • 18.6.3. Deployment Mode
      • 18.6.4. Therapeutic Area
      • 18.6.5. Functionality
      • 18.6.6. Integration Type
      • 18.6.7. User Type
      • 18.6.8. Technology
      • 18.6.9. Application
      • 18.6.10. End User
    • 18.7. South Korea Patient Engagement Solutions Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Component
      • 18.7.3. Deployment Mode
      • 18.7.4. Therapeutic Area
      • 18.7.5. Functionality
      • 18.7.6. Integration Type
      • 18.7.7. User Type
      • 18.7.8. Technology
      • 18.7.9. Application
      • 18.7.10. End User
    • 18.8. Australia and New Zealand Patient Engagement Solutions Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Component
      • 18.8.3. Deployment Mode
      • 18.8.4. Therapeutic Area
      • 18.8.5. Functionality
      • 18.8.6. Integration Type
      • 18.8.7. User Type
      • 18.8.8. Technology
      • 18.8.9. Application
      • 18.8.10. End User
    • 18.9. Indonesia Patient Engagement Solutions Market
      • 18.9.1. Country Segmental Analysis
      • 18.9.2. Component
      • 18.9.3. Deployment Mode
      • 18.9.4. Therapeutic Area
      • 18.9.5. Functionality
      • 18.9.6. Integration Type
      • 18.9.7. User Type
      • 18.9.8. Technology
      • 18.9.9. Application
      • 18.9.10. End User
    • 18.10. Malaysia Patient Engagement Solutions Market
      • 18.10.1. Country Segmental Analysis
      • 18.10.2. Component
      • 18.10.3. Deployment Mode
      • 18.10.4. Therapeutic Area
      • 18.10.5. Functionality
      • 18.10.6. Integration Type
      • 18.10.7. User Type
      • 18.10.8. Technology
      • 18.10.9. Application
      • 18.10.10. End User
    • 18.11. Thailand Patient Engagement Solutions Market
      • 18.11.1. Country Segmental Analysis
      • 18.11.2. Component
      • 18.11.3. Deployment Mode
      • 18.11.4. Therapeutic Area
      • 18.11.5. Functionality
      • 18.11.6. Integration Type
      • 18.11.7. User Type
      • 18.11.8. Technology
      • 18.11.9. Application
      • 18.11.10. End User
    • 18.12. Vietnam Patient Engagement Solutions Market
      • 18.12.1. Country Segmental Analysis
      • 18.12.2. Component
      • 18.12.3. Deployment Mode
      • 18.12.4. Therapeutic Area
      • 18.12.5. Functionality
      • 18.12.6. Integration Type
      • 18.12.7. User Type
      • 18.12.8. Technology
      • 18.12.9. Application
      • 18.12.10. End User
    • 18.13. Rest of Asia Pacific Patient Engagement Solutions Market
      • 18.13.1. Country Segmental Analysis
      • 18.13.2. Component
      • 18.13.3. Deployment Mode
      • 18.13.4. Therapeutic Area
      • 18.13.5. Functionality
      • 18.13.6. Integration Type
      • 18.13.7. User Type
      • 18.13.8. Technology
      • 18.13.9. Application
      • 18.13.10. End User
  • 19. Middle East Patient Engagement Solutions Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Middle East Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Component
      • 19.3.2. Deployment Mode
      • 19.3.3. Therapeutic Area
      • 19.3.4. Functionality
      • 19.3.5. Integration Type
      • 19.3.6. User Type
      • 19.3.7. Technology
      • 19.3.8. Application
      • 19.3.9. End User
      • 19.3.10. Country
        • 19.3.10.1. Turkey
        • 19.3.10.2. UAE
        • 19.3.10.3. Saudi Arabia
        • 19.3.10.4. Israel
        • 19.3.10.5. Rest of Middle East
    • 19.4. Turkey Patient Engagement Solutions Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Component
      • 19.4.3. Deployment Mode
      • 19.4.4. Therapeutic Area
      • 19.4.5. Functionality
      • 19.4.6. Integration Type
      • 19.4.7. User Type
      • 19.4.8. Technology
      • 19.4.9. Application
      • 19.4.10. End User
    • 19.5. UAE Patient Engagement Solutions Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Component
      • 19.5.3. Deployment Mode
      • 19.5.4. Therapeutic Area
      • 19.5.5. Functionality
      • 19.5.6. Integration Type
      • 19.5.7. User Type
      • 19.5.8. Technology
      • 19.5.9. Application
      • 19.5.10. End User
    • 19.6. Saudi Arabia Patient Engagement Solutions Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Component
      • 19.6.3. Deployment Mode
      • 19.6.4. Therapeutic Area
      • 19.6.5. Functionality
      • 19.6.6. Integration Type
      • 19.6.7. User Type
      • 19.6.8. Technology
      • 19.6.9. Application
      • 19.6.10. End User
    • 19.7. Israel Patient Engagement Solutions Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Component
      • 19.7.3. Deployment Mode
      • 19.7.4. Therapeutic Area
      • 19.7.5. Functionality
      • 19.7.6. Integration Type
      • 19.7.7. User Type
      • 19.7.8. Technology
      • 19.7.9. Application
      • 19.7.10. End User
    • 19.8. Rest of Middle East Patient Engagement Solutions Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Component
      • 19.8.3. Deployment Mode
      • 19.8.4. Therapeutic Area
      • 19.8.5. Functionality
      • 19.8.6. Integration Type
      • 19.8.7. User Type
      • 19.8.8. Technology
      • 19.8.9. Application
      • 19.8.10. End User
  • 20. Africa Patient Engagement Solutions Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. Africa Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Component
      • 20.3.2. Deployment Mode
      • 20.3.3. Therapeutic Area
      • 20.3.4. Functionality
      • 20.3.5. Integration Type
      • 20.3.6. User Type
      • 20.3.7. Technology
      • 20.3.8. Application
      • 20.3.9. End User
      • 20.3.10. Country
        • 20.3.10.1. South Africa
        • 20.3.10.2. Egypt
        • 20.3.10.3. Nigeria
        • 20.3.10.4. Algeria
        • 20.3.10.5. Rest of Africa
    • 20.4. South Africa Patient Engagement Solutions Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Component
      • 20.4.3. Deployment Mode
      • 20.4.4. Therapeutic Area
      • 20.4.5. Functionality
      • 20.4.6. Integration Type
      • 20.4.7. User Type
      • 20.4.8. Technology
      • 20.4.9. Application
      • 20.4.10. End User
    • 20.5. Egypt Patient Engagement Solutions Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Component
      • 20.5.3. Deployment Mode
      • 20.5.4. Therapeutic Area
      • 20.5.5. Functionality
      • 20.5.6. Integration Type
      • 20.5.7. User Type
      • 20.5.8. Technology
      • 20.5.9. Application
      • 20.5.10. End User
    • 20.6. Nigeria Patient Engagement Solutions Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Component
      • 20.6.3. Deployment Mode
      • 20.6.4. Therapeutic Area
      • 20.6.5. Functionality
      • 20.6.6. Integration Type
      • 20.6.7. User Type
      • 20.6.8. Technology
      • 20.6.9. Application
      • 20.6.10. End User
    • 20.7. Algeria Patient Engagement Solutions Market
      • 20.7.1. Country Segmental Analysis
      • 20.7.2. Component
      • 20.7.3. Deployment Mode
      • 20.7.4. Therapeutic Area
      • 20.7.5. Functionality
      • 20.7.6. Integration Type
      • 20.7.7. User Type
      • 20.7.8. Technology
      • 20.7.9. Application
      • 20.7.10. End User
    • 20.8. Rest of Africa Patient Engagement Solutions Market
      • 20.8.1. Country Segmental Analysis
      • 20.8.2. Component
      • 20.8.3. Deployment Mode
      • 20.8.4. Therapeutic Area
      • 20.8.5. Functionality
      • 20.8.6. Integration Type
      • 20.8.7. User Type
      • 20.8.8. Technology
      • 20.8.9. Application
      • 20.8.10. End User
  • 21. South America Patient Engagement Solutions Market Analysis
    • 21.1. Key Segment Analysis
    • 21.2. Regional Snapshot
    • 21.3. South America Patient Engagement Solutions Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 21.3.1. Component
      • 21.3.2. Deployment Mode
      • 21.3.3. Therapeutic Area
      • 21.3.4. Functionality
      • 21.3.5. Integration Type
      • 21.3.6. User Type
      • 21.3.7. Technology
      • 21.3.8. Application
      • 21.3.9. End User
      • 21.3.10. Country
        • 21.3.10.1. Brazil
        • 21.3.10.2. Argentina
        • 21.3.10.3. Rest of South America
    • 21.4. Brazil Patient Engagement Solutions Market
      • 21.4.1. Country Segmental Analysis
      • 21.4.2. Component
      • 21.4.3. Deployment Mode
      • 21.4.4. Therapeutic Area
      • 21.4.5. Functionality
      • 21.4.6. Integration Type
      • 21.4.7. User Type
      • 21.4.8. Technology
      • 21.4.9. Application
      • 21.4.10. End User
    • 21.5. Argentina Patient Engagement Solutions Market
      • 21.5.1. Country Segmental Analysis
      • 21.5.2. Component
      • 21.5.3. Deployment Mode
      • 21.5.4. Therapeutic Area
      • 21.5.5. Functionality
      • 21.5.6. Integration Type
      • 21.5.7. User Type
      • 21.5.8. Technology
      • 21.5.9. Application
      • 21.5.10. End User
    • 21.6. Rest of South America Patient Engagement Solutions Market
      • 21.6.1. Country Segmental Analysis
      • 21.6.2. Component
      • 21.6.3. Deployment Mode
      • 21.6.4. Therapeutic Area
      • 21.6.5. Functionality
      • 21.6.6. Integration Type
      • 21.6.7. User Type
      • 21.6.8. Technology
      • 21.6.9. Application
      • 21.6.10. End User
  • 22. Key Players/ Company Profile
    • 22.1. AdvancedMD, Inc.
      • 22.1.1. Company Details/ Overview
      • 22.1.2. Company Financials
      • 22.1.3. Key Customers and Competitors
      • 22.1.4. Business/ Industry Portfolio
      • 22.1.5. Product Portfolio/ Specification Details
      • 22.1.6. Pricing Data
      • 22.1.7. Strategic Overview
      • 22.1.8. Recent Developments
    • 22.2. athenahealth, Inc.
    • 22.3. CareCloud, Inc.
    • 22.4. Cerner Corporation
    • 22.5. Cognizant Technology Solutions Corporation
    • 22.6. eClinicalWorks LLC
    • 22.7. Epic Systems Corporation
    • 22.8. Get Real Health
    • 22.9. GetWellNetwork, Inc.
    • 22.10. IBM Corporation
    • 22.11. IQVIA Inc.
    • 22.12. McKesson Corporation
    • 22.13. MEDITECH
    • 22.14. Oneview Healthcare PLC
    • 22.15. Oracle Corporation
    • 22.16. Orion Health Group Limited
    • 22.17. Phreesia, Inc.
    • 22.18. Tebra Technologies, Inc.
    • 22.19. Veradigm Inc.
    • 22.20. Wolters Kluwer N.V.
    • 22.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation